Research shows that L-serine, an amino acid that helps brain cells grow and survive, is reduced in Alzheimer’s disease. In a study with mice genetically engineered to develop Alzheimer’s symptoms, a diet enriched with L-serine for 4 to 8 months significantly restored the growth of new brain cells in the hippocampus, the memory center of the brain. According to Gram Research analysis, this finding suggests L-serine supplementation may protect memory-related neurons in Alzheimer’s disease, though human trials are needed to confirm these results.
Researchers discovered that a building block called L-serine, which helps brain cells grow and survive, is reduced in people with Alzheimer’s disease. In a study with mice that mimic Alzheimer’s, scientists found that adding L-serine to their diet helped restore the growth of new brain cells in a memory-related area called the hippocampus. According to Gram Research analysis, this finding suggests that boosting L-serine levels might be a new way to fight some of the brain damage caused by Alzheimer’s, though more research in humans is needed to confirm these results.
Key Statistics
A 2026 research article in the Journal of Alzheimer’s Disease found that 12-month-old mice with Alzheimer’s disease showed significantly reduced growth of new brain cells compared to healthy mice, but L-serine supplementation for 4 to 8 months partially restored this neurogenesis deficit.
In the same 2026 study, an L-serine-enriched diet successfully raised blood levels of both L-serine and D-serine in mice with Alzheimer’s disease, indicating the supplementation was being absorbed and processed by the body.
Researchers confirmed that PHGDH, the enzyme responsible for producing L-serine in the brain, was present in neural stem cells in both mouse and human brain tissue, suggesting the L-serine production system could potentially be targeted in people with Alzheimer’s disease.
The Quick Take
- What they studied: Whether adding more L-serine, a natural protein building block, could help restore the growth of new brain cells in mice with Alzheimer’s disease
- Who participated: 7-month-old and 12-month-old mice genetically engineered to develop Alzheimer’s disease symptoms, compared with healthy mice of the same age
- Key finding: Mice with Alzheimer’s that received an L-serine-enriched diet for 4 to 8 months showed significant improvement in the growth of new brain cells in the hippocampus, the brain region responsible for memory
- What it means for you: This research suggests that L-serine supplementation might help protect memory-related brain cells in Alzheimer’s disease, but these results are from animal studies and need to be tested in humans before any recommendations can be made
The Research Details
Scientists studied mice that were genetically modified to develop Alzheimer’s disease symptoms similar to humans. They examined how well brain cells were growing in a specific brain region called the dentate gyrus, which is part of the hippocampus and is crucial for memory formation. The researchers looked at whether an enzyme called PHGDH, which makes L-serine, was working properly in these mice. They then gave some mice a diet enriched with L-serine for either 4 or 8 months and measured whether this improved brain cell growth. They also checked blood levels of L-serine and D-serine, a related molecule, to see if the diet actually increased these compounds in the body.
This research approach is important because it identifies a specific biological problem in Alzheimer’s disease (reduced L-serine production) and tests whether fixing that problem can restore normal brain cell growth. By using mice that naturally develop Alzheimer’s-like symptoms, the researchers could observe how L-serine supplementation affects the disease in a living brain. This type of study helps scientists understand the mechanisms behind Alzheimer’s and identify potential treatments before testing them in humans.
This study was published in the Journal of Alzheimer’s Disease, a peer-reviewed scientific journal focused on Alzheimer’s research. The researchers examined both mouse and human brain tissue to confirm their findings were relevant to people. However, the study was conducted in mice, not humans, so results may not directly translate to how L-serine would work in people with Alzheimer’s disease. The study did not measure whether L-serine supplementation affected the buildup of amyloid proteins, which are a hallmark of Alzheimer’s, suggesting the benefits work through a different mechanism.
What the Results Show
The researchers found that 12-month-old mice with Alzheimer’s disease had significantly fewer growing brain cells compared to healthy mice of the same age. Specifically, they measured two types of cells: cells actively dividing (marked by PCNA) and immature neurons (marked by DCX), and both were reduced in the Alzheimer’s mice. When these mice received an L-serine-enriched diet for 4 to 8 months, the number of these growing brain cells increased substantially, partially restoring the neurogenesis deficit. The diet successfully raised blood levels of both L-serine and D-serine, indicating that the supplementation was being absorbed and processed by the body. Importantly, the L-serine supplementation did not reduce amyloid plaques, the protein clumps that accumulate in Alzheimer’s brains, suggesting it works through a separate mechanism focused on protecting new brain cell survival rather than clearing existing damage.
The researchers confirmed that an enzyme called PHGDH, which is responsible for making L-serine in the brain, was present in neural stem cells in both mouse and human brain tissue. This finding suggests that the L-serine production system exists in human brains and could potentially be targeted in people with Alzheimer’s disease. The fact that L-serine supplementation partially, rather than completely, restored neurogenesis suggests that while L-serine deficiency is part of the problem in Alzheimer’s, other factors also contribute to impaired brain cell growth.
Previous research has shown that adult neurogenesis, the growth of new brain cells in adult brains, is impaired in Alzheimer’s disease in both humans and animal models. This study builds on that knowledge by identifying a specific cause: reduced L-serine availability. Earlier work demonstrated that L-serine is important for cell growth and survival, but this is the first study to directly test whether boosting L-serine can restore brain cell growth in Alzheimer’s disease. The findings align with research showing that metabolic problems in the brain contribute to Alzheimer’s symptoms, expanding the focus beyond just amyloid and tau proteins.
This study was conducted entirely in mice, so the results may not directly apply to humans with Alzheimer’s disease. The researchers did not test whether L-serine supplementation improved memory or other cognitive functions in the mice, only whether it increased brain cell growth. The study did not explore optimal dosing or duration of L-serine supplementation. Additionally, the researchers did not investigate whether L-serine supplementation would work in early-stage Alzheimer’s or only in advanced disease. The study also did not examine potential side effects of long-term L-serine supplementation.
The Bottom Line
Based on this animal research, L-serine supplementation shows promise as a potential treatment for Alzheimer’s disease, but human clinical trials are needed before any recommendations can be made. People with Alzheimer’s or at risk for the disease should not start taking L-serine supplements based on this study alone. Discuss any interest in L-serine supplementation with a healthcare provider, as it is not yet an established treatment. The confidence level for these findings is moderate, as they come from animal studies that still need to be validated in humans.
Researchers studying Alzheimer’s disease and neurodegenerative conditions should pay attention to these findings as they suggest a new therapeutic target. People with Alzheimer’s disease or a family history of Alzheimer’s may find this research interesting, but should not change their diet or supplement regimen based on this study alone. Healthcare providers treating Alzheimer’s patients should be aware of this emerging research. People should not assume that eating foods high in L-serine will provide the same benefits as the controlled supplementation used in this study.
In the mouse study, improvements in brain cell growth were observed after 4 to 8 months of L-serine supplementation. If similar research were conducted in humans, it would likely take months to years to see measurable improvements in brain function or memory. Any human clinical trials would need to run for extended periods to determine whether L-serine supplementation can slow cognitive decline in Alzheimer’s disease.
Frequently Asked Questions
Can L-serine supplements help prevent or treat Alzheimer’s disease?
L-serine supplementation restored brain cell growth in mice with Alzheimer’s disease, but this has not been tested in humans. More research is needed before L-serine can be recommended as a treatment. Talk to your doctor before starting any supplements.
What foods contain L-serine naturally?
L-serine is found in protein-rich foods including eggs, dairy products, soy, wheat, and meat. A balanced diet typically provides adequate L-serine for most people, though this study tested supplementation beyond normal dietary levels.
How does L-serine help the brain in Alzheimer’s disease?
L-serine is a building block that helps brain cells grow and survive. In Alzheimer’s disease, L-serine production is reduced, which impairs the growth of new brain cells in the memory center. Supplementation may restore this process.
When will L-serine supplements be available as an Alzheimer’s treatment?
This mouse study is an early-stage finding. Human clinical trials would need to be conducted and approved by regulatory agencies before L-serine could be recommended as a treatment. This process typically takes several years.
Does L-serine supplementation reduce amyloid plaques in Alzheimer’s?
No, the study found that L-serine supplementation did not reduce amyloid plaques, the protein clumps that accumulate in Alzheimer’s brains. Instead, it appears to work by protecting new brain cell survival through a different mechanism.
Want to Apply This Research?
- Track daily dietary sources of L-serine (found in eggs, dairy, soy, and wheat) and monitor cognitive function through memory tests or journaling to establish a baseline if considering L-serine supplementation in the future
- Users interested in supporting brain health can log foods rich in L-serine and track overall diet quality, while setting reminders to discuss emerging Alzheimer’s research with their healthcare provider
- Create a long-term tracking system for cognitive wellness markers such as memory performance, mood, and sleep quality to establish personal baselines before any potential future interventions, and review progress quarterly with a healthcare provider
This research was conducted in mice with genetically engineered Alzheimer’s disease and has not been tested in humans. L-serine supplementation is not currently an approved treatment for Alzheimer’s disease. Do not start taking L-serine supplements or change your diet based on this study without consulting your healthcare provider. If you or a loved one has been diagnosed with Alzheimer’s disease or cognitive decline, work with your medical team to develop an evidence-based treatment plan. This article is for informational purposes only and should not be considered medical advice.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.